Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Progress in adult ALL: incorporation of new agents to frontline treatment.
A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids.
Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.
MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.
MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale. Mol Cancer Ther. 2017 04; 16(4):555-565.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Apoptosis
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Cell Movement
Cell Proliferation
Drug Resistance, Neoplasm
Female
Gene Amplification
Hepatocyte Growth Factor
Humans
Lung Neoplasms
Male
Mutation
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Signal Transduction
authors with profiles
Ravi Salgia